Consequently, if the PSA level of diabetic patients would exceed the prostate biopsy indication despite the aforementioned hormonal imbalance, the prostate cancer risk would be increased paradoxically in DM patients, especially in the DM+PC group. Here, KLK3 is linked to diabetes mellitus.